SAM
SRPT icon

Sectoral Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Sectoral Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,020
Closed -$1.34M – 96
2024
Q4 		$1.34M Sell
11,020
-1,296
-11% -$159K 0.89% 29
2024
Q3 		$1.54M Sell
12,316
-1,180
-9% -$163K 0.91% 31
2024
Q2 		$2.13M Sell
13,496
-3,795
-22% -$488K 0.87% 35
2024
Q1 		$2.24M Sell
17,291
-4,250
-20% -$521K 0.88% 36
2023
Q4 		$2.08M Buy
21,541
+3,535
+20% +$339K 0.89% 40
2023
Q3 		$2.18M Sell
18,006
-34,443
-66% -$3.89M 0.43% 79
2023
Q2 		$6.01M Buy
52,449
+27,739
+112% +$3.58M 1% 42
2023
Q1 		$3.41M Buy
24,710
+21,910
+783% +$2.84M 0.65% 64
2022
Q4 		$363K Hold
2,800
– – 0.07% 108
2022
Q3 		$310K Hold
2,800
– – 0.06% 99
2022
Q2 		$210K Buy
+2,800
New +$206K 0.04% 103
2021
Q1 		– Sell
-86,624
Closed -$14.8M – 130
2020
Q4 		$14.8M Sell
86,624
-5,650
-6% -$837K 1.04% 39
2020
Q3 		$13M Buy
92,274
+4,500
+5% +$684K 1.11% 38
2020
Q2 		$14.1M Sell
87,774
-38,985
-31% -$5.31M 1.29% 35
2020
Q1 		$12.4M Buy
126,759
+69,999
+123% +$8M 2.38% 8
2019
Q4 		$7.32M Sell
56,760
-27,638
-33% -$2.79M 1.09% 38
2019
Q3 		$6.36M Sell
84,398
-32,699
-28% -$3.86M 1.1% 39
2019
Q2 		$17.8M Sell
117,097
-11,001
-9% -$1.34M 2.13% 13
2019
Q1 		$15.3M Buy
+128,098
New +$16.5M 1.84% 17
2018
Q4 		– Sell
-27,000
Closed -$4.36M – 131
2018
Q3 		$4.36M Sell
27,000
-178,699
-87% -$24.4M 0.46% 57
2018
Q2 		$27.2M Sell
205,699
-121,999
-37% -$11.5M 3.04% 9
2018
Q1 		$24.3M Buy
327,698
+88,699
+37% +$5.91M 2.66% 12
2017
Q4 		$13.3M Buy
238,999
+169,900
+246% +$9M 1.66% 25
2017
Q3 		$3.13M Buy
69,099
+40,300
+140% +$1.61M 0.4% 50
2017
Q2 		$971K Hold
28,799
– – 0.11% 57
2017
Q1 		$852K Hold
28,799
– – 0.1% 60
2016
Q4 		$790K Buy
+28,799
New +$1.16M 0.09% 51

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Sectoral Asset Management's SRPT Position: Q1 2025 in Review

Sectoral Asset Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 11,020 shares — an estimated $1.34M sold.

Sectoral Asset Management first reported a position in SRPT in Q4 2016 and held it in 27 quarters. The position peaked at $27.2M in Q2 2018. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Sectoral Asset Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 11,020 Sarepta Therapeutics shares in Q1 2025, an estimated $1.34M.
  • Sectoral Asset Management first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 27 quarters.
  • Sectoral Asset Management's Sarepta Therapeutics position peaked at $27.2M in Q2 2018.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.